124 related articles for article (PubMed ID: 5576836)
1. Oestrogens for carcinoma of the prostate.
Med J Aust; 1971 May; 1(19):991-2. PubMed ID: 5576836
[No Abstract] [Full Text] [Related]
2. Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate.
Blackard CE; Doe RP; Mellinger GT; Byar DP
Cancer; 1970 Aug; 26(2):249-56. PubMed ID: 4916019
[No Abstract] [Full Text] [Related]
3. Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo.
Bailar JC; Byar DP
Cancer; 1970 Aug; 26(2):257-61. PubMed ID: 4916020
[No Abstract] [Full Text] [Related]
4. Estrogens and cancer of the prostate.
Kaplan L
Surg Gynecol Obstet; 1969 Jan; 128(1):117. PubMed ID: 5774991
[No Abstract] [Full Text] [Related]
5. Estrogen and survival data in carcinoma of the prostate.
Bennett AH; Dowd JB; Harrison JH
Surg Gynecol Obstet; 1970 Mar; 130(3):505-8. PubMed ID: 4905115
[No Abstract] [Full Text] [Related]
6. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
[TBL] [Abstract][Full Text] [Related]
7. The question of stilbestrol in the treatment of prostatic carcinoma.
Lawrence W; Horsley JS
Va Med Mon (1918); 1968 Apr; 95(4):238-40. PubMed ID: 5645075
[No Abstract] [Full Text] [Related]
8. Yet another adverse effect of DES exposure.
Chinn ND
RN; 1990 Oct; 53(10):9. PubMed ID: 2218330
[No Abstract] [Full Text] [Related]
9. Effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
Mackler MA; Liberti JP; Smith MJ; Prout GR
Surg Forum; 1970; 21():540-1. PubMed ID: 5535268
[No Abstract] [Full Text] [Related]
10. Profound hypocalcaemia associated with oestrogen treatment of carcinoma of the prostate.
Harley HA; Mason R; Phillips PJ
Med J Aust; 1983 Jul; 2(1):41-2. PubMed ID: 6865830
[TBL] [Abstract][Full Text] [Related]
11. Hepatoma associated with diethylstilbestrol therapy for prostatic carcinoma.
Brooks JJ
J Urol; 1982 Nov; 128(5):1044-5. PubMed ID: 6294349
[No Abstract] [Full Text] [Related]
12. Editorial: Stilboestrol: use and abuse in prostatic disease.
N Z Med J; 1974 Aug; 80(521):113. PubMed ID: 4529401
[No Abstract] [Full Text] [Related]
13. Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group.
Pavone-Macaluso M; de Voogt HJ; Viggiano G; Barasolo E; Lardennois B; de Pauw M; Sylvester R
J Urol; 1986 Sep; 136(3):624-31. PubMed ID: 2942707
[TBL] [Abstract][Full Text] [Related]
14. [Diethyl-stilbestrol for treatment of prostatic carcinoma].
Cifuentes Delatte L
Arch Esp Urol; 1990 Sep; 43(7):697-704. PubMed ID: 2125823
[No Abstract] [Full Text] [Related]
15. Thrombosis and carcinoma of the prostate.
Sutherland-Rawlings E
Br Med J; 1970 Sep; 3(5723):643-4. PubMed ID: 5470096
[No Abstract] [Full Text] [Related]
16. Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
Moffat LE
Eur Urol; 1990; 18 Suppl 3():26-7. PubMed ID: 2151272
[No Abstract] [Full Text] [Related]
17. Editorial: Stilboestrol for prostatic cancer.
Br Med J; 1974 Jun; 2(5918):520. PubMed ID: 4407126
[No Abstract] [Full Text] [Related]
18. Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate.
Byar DP
Cancer; 1973 Nov; 32(5):1126-30. PubMed ID: 4585929
[No Abstract] [Full Text] [Related]
19. Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762.
de Voogt HJ; Smith PH; Pavone-Macaluso M; de Pauw M; Suciu S
J Urol; 1986 Feb; 135(2):303-7. PubMed ID: 2935644
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular complications in the treatment of prostatic carcinoma.
Glashan RW; Robinson MR
Br J Urol; 1981 Dec; 53(6):624-7. PubMed ID: 7317753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
